drugset / Trial / NCT06780644
Comparison of Effectiveness and Safety of Triple Combination Cream of Fucinolone Acetonide 0.01%, Hydroquinone 4%, Tretinoin 0.05% with Mometasone Furoate 0.1%, Hydroquinone 4%, Tretinoin 0.05% in the Treatment of Melasma
RandomizedParallel-groupSingle-blindTreatment
Summary
This Research is a clinical study with a single-blind randomized controlled trial of evaluators. Clinical trial Randomized Controlled Trial (RCT) design that compares the use of a triple combination cream of flucinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05% with a triple cream combination of mometasone furoate 0.1%, hydroquinone 4%, tretinoin 0.05% in melasma therapy in RSCM-FKUI. This study aims to Assess the effectiveness and safety of Triple Combination Cream of Fucinolone Acetonide 0.01%, Hydroquinone 4%, Tretinoin 0.05% with Mometasone Furoate 0.1%, Hydroquinone 4%, Tretinoin 0.05% in melasma patients
Timeline
- Start
- 2025-02-17
- Primary completion
- 2025-05-26
- Completion
- 2025-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hydroquinone | Small molecule | 4 % | Topical |
| Subject | Hydroquinone | Small molecule | 40 mg | Topical |
| Subject | Mometasone furoate | Other / unclassified | 0.1 % | Topical |
| Subject | Tretinoin | Small molecule | 0.05 % | Topical |
| Subject | Tretinoin | Small molecule | 0.5 mg | Topical |
| Subject | fluocinolone acetonide | Small molecule | 0.1 mg | Topical |